PHK
MRNA icon

Point72 Hong Kong’s Moderna MRNA Stock Holding History

Point72 Hong Kong’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-7,892
Closed -$218K – 577
2025
Q2 		$218K Buy
+7,892
New +$208K 0.01% 302
2021
Q4 		– Sell
-5,433
Closed -$2.09M – 2200
2021
Q3 		$2.09M Buy
+5,433
New +$2M 0.07% 446
2021
Q1 		– Sell
-1,665
Closed -$174K – 2070
2020
Q4 		$174K Sell
1,665
-21,447
-93% -$2.17M 0.01% 961
2020
Q3 		$1.64M Buy
+23,112
New +$1.61M 0.17% 141
2019
Q1 		– Sell
-33,319
Closed -$509K – 1191
2018
Q4 		$509K Buy
+33,319
New +$548K 0.24% 28

Other funds holding MRNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Point72 Hong Kong's MRNA Position: Q3 2025 in Review

Point72 Hong Kong sold out of Moderna (MRNA) in Q3 2025, closing a stake of 7,892 shares — an estimated $218K sold.

Point72 Hong Kong first reported a position in MRNA in Q4 2018 and held it in 5 quarters. The position peaked at $2.09M in Q3 2021. 644 funds tracked by Wall St. Rank hold MRNA as of Q3 2025.

  • Point72 Hong Kong reported no remaining Moderna position as of Q3 2025 after selling out during the quarter.
  • Point72 Hong Kong sold 7,892 Moderna shares in Q3 2025, an estimated $218K.
  • Point72 Hong Kong first reported a position in Moderna in Q4 2018 and held it in 5 quarters.
  • Point72 Hong Kong's Moderna position peaked at $2.09M in Q3 2021.
  • 644 funds tracked by Wall St. Rank held Moderna as of Q3 2025.

Based on Point72 Hong Kong's 13F filing for Q3 2025, filed 14 Nov 2025.